デフォルト表紙
市場調査レポート
商品コード
1610000

非オピオイド鎮痛パッチの市場規模、シェア、動向分析レポート:パッチタイプ別、流通チャネル別、地域別、セグメント予測、2025年~2030年

Non-opioid Pain Patches Market Size, Share & Trends Analysis Report By Patch Type (Lidocaine, Diclofenac, Methyl Salicylate, Capsaicin, Ketoprofen), By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030


出版日
ページ情報
英文 100 Pages
納期
2~10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.30円
非オピオイド鎮痛パッチの市場規模、シェア、動向分析レポート:パッチタイプ別、流通チャネル別、地域別、セグメント予測、2025年~2030年
出版日: 2024年11月12日
発行: Grand View Research
ページ情報: 英文 100 Pages
納期: 2~10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

非オピオイド鎮痛パッチ市場の成長と動向

Grand View Research, Inc.の最新レポートによると、世界の非オピオイド鎮痛パッチ市場規模は2030年までに14億米ドルに達し、予測期間中にCAGR 6.2%で拡大すると予測されています。

市場を牽引する主要要因としては、疼痛関連疾患の罹患率の上昇と、急性と慢性の疼痛を緩和するために使用される他の形態の薬剤と比較して、これらのパッチが提供する様々な利点が挙げられます。

AAPMによると、慢鎮痛は米国においてがん、糖尿病、冠状動脈性心疾患の合計よりも多くの人に影響を及ぼしています。米国カイロプラクティック協会の推定によると、米国市民は背中に関連する病気に毎年少なくとも500億米ドルを費やしています。これらの事実は、世界的に痛みを和らげる治療法の必要性が高まっていることを示しています。

オピオイド薬は通常、疼痛や関連疾患の治療として求められるが、患者の大半は依存や乱用を引き起こしています。オピオイド薬への依存の高まりは、不快感を緩和する代替療法の開発を多くの国に促しています。2017年11月、米国のオピオイド流行は国家非常事態として宣言されました。そのため、副作用を軽減して根本的な不快感を和らげる安全で効果的な治療法の需要が各国政府に求められており、市場の成長を加速させています。

Substance Abuse and Mental Health Services Administration(薬剤乱用・精神衛生管理局)が2015年に発表した新しい調査によると、アメリカでは成人の3人に1人が医療提供者から鎮痛剤を配合されています。また、同報告書の統計によると、これらの薬剤は、タバコ、葉巻、無煙タバコを合わせたよりも多く使用されています。これらの内服薬のほとんどはアヘン系に分類され、通常、依存性が高く、アルコールや他の薬剤など他の消耗品と併用されやすいです。これらの薬剤に関連する副作用に関する意識の高まりは、同じ治療効果をもたらし疼痛管理を助ける非オピオイド鎮痛パッチなどの代替品の開発につながりました。

非オピオイド鎮痛パッチ市場レポートハイライト

  • 神経障害鎮痛や筋骨格系疼痛など、さまざまな種類の疼痛を緩和する有効性が確立されていることから、2024年にはリコダインパッチが35.0%の最大市場シェアを占めました。
  • 2024年の売上シェアは44.6%で、小売薬局が市場を独占しています。様々な非オピオイド鎮痛パッチが市販されており、配合箋なしで購入することができます。
  • 北米は、非オピオイド鎮痛パッチ市場の大手企業が現地に存在し、患者数の増加に対応するために疼痛管理セグメントでの研究開発が増加していることから、最大の収益シェアを占めています。
  • アジア太平洋は、同地域の有力企業による投資の増加や、インドや中国などの新興諸国における医薬品産業の開発により、予測期間中に最も高いCAGRを占めると予想されます。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 非オピオイド鎮痛パッチ市場の変数、動向、範囲

  • 市場系統の展望
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • ビジネス環境分析
    • 産業分析-ポーターのファイブフォース分析
    • PESTLE分析

第4章 非オピオイド鎮痛パッチ市場:パッチタイプビジネス分析

  • パッチタイプの市場シェア、2024年と2030年
  • パッチタイプセグメントダッシュボード
  • 市場規模と予測と動向分析、パッチタイプ別、2018~2030年
  • リドカインパッチ
  • ジクロフェナクパッチ
  • メチルサリチル酸パッチ
  • カプサイシンパッチ
  • ケトプロフェンパッチ
  • その他(ハーブ、メントールなど)

第5章 非オピオイド鎮痛パッチ市場:流通チャネルビジネス分析

  • 流通チャネル市場シェア、2024年と2030年
  • 流通チャネルセグメントダッシュボード
  • 市場規模と予測と動向分析、流通チャネル別、2018~2030年
  • 小売薬局
  • 病院薬局
  • オンライン薬局
  • その他(スーパーマーケット/ハイパーマーケット、DTC)

第6章 非オピオイド鎮痛パッチ市場:パッチタイプ、流通チャネル、地域別、推定・動向分析

  • 地域別市場シェア分析、2024年と2030年
  • 地域別市場ダッシュボード
  • 市場規模、予測動向分析、2018~2030年
  • 北米
    • 国別、2018~2030年
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 国別、2018~2030年
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • ノルウェー
    • デンマーク
    • スウェーデン
  • アジア太平洋
    • 国別、2018~2030年
    • 日本
    • 中国
    • インド
    • 韓国
    • オーストラリア
    • タイ
  • ラテンアメリカ
    • 国別、2018~2030年
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • 国別、2018~2030年
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第7章 競合情勢

  • 参加者概要
  • 企業の市況分析
  • 企業分類
  • 戦略マッピング
  • 企業プロファイル/上場企業
    • Acorda Therapeutics, Inc.
    • Teva Pharmaceutical Industries Ltd.
    • GSK plc
    • Endo, Inc.
    • Hisamitsu Pharmaceutical Co.,Inc.
    • IBSA Institut Biochimique SA
    • Alkermes
    • Teikoku Pharma
    • Mylan NV
図表

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global non-opioid pain patches market, by region, 2018 - 2030 (USD Million)
  • Table 4 Global non-opioid pain patches market, by patch type, 2018 - 2030 (USD Million)
  • Table 5 Global non-opioid pain patches market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 6 North America non-opioid pain patches market, by country, 2018 - 2030 (USD Million)
  • Table 7 North America non-opioid pain patches market, by patch type, 2018 - 2030 (USD Million)
  • Table 8 North America non-opioid pain patches market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 9 U.S. non-opioid pain patches market, by patch type, 2018 - 2030 (USD Million)
  • Table 10 U.S. Non-opioid pain patches market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 11 Canada non-opioid pain patches market, by patch type, 2018 - 2030 (USD Million)
  • Table 12 Canada non-opioid pain patches market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 13 Mexico non-opioid pain patches market, by patch type, 2018 - 2030 (USD Million)
  • Table 14 Mexico non-opioid pain patches market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 15 Europe non-opioid pain patches market, by country, 2018 - 2030 (USD Million)
  • Table 16 Europe non-opioid pain patches market, by patch type, 2018 - 2030 (USD Million)
  • Table 17 Europe non-opioid pain patches market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 18 UK non-opioid pain patches market, by patch type, 2018 - 2030 (USD Million)
  • Table 19 UK non-opioid pain patches market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 20 Germany non-opioid pain patches market, by patch type, 2018 - 2030 (USD Million)
  • Table 21 Germany non-opioid pain patches market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 22 France non-opioid pain patches market, by patch type, 2018 - 2030 (USD Million)
  • Table 23 France Non-opioid pain patches market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 24 Italy non-opioid pain patches market, by patch type, 2018 - 2030 (USD Million)
  • Table 25 Italy non-opioid pain patches market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 26 Spain non-opioid pain patches market, by patch type, 2018 - 2030 (USD Million)
  • Table 27 Spain non-opioid pain patches market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 28 Norway non-opioid pain patches market, by patch type, 2018 - 2030 (USD Million)
  • Table 29 Norway Non-opioid pain patches market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 30 Denmark non-opioid pain patches market, by patch type, 2018 - 2030 (USD Million)
  • Table 31 Denmark non-opioid pain patches market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 32 Sweden non-opioid pain patches market, by patch type, 2018 - 2030 (USD Million)
  • Table 33 Sweden non-opioid pain patches market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 34 Asia Pacific non-opioid pain patches market, by country, 2018 - 2030 (USD Million)
  • Table 35 Asia Pacific non-opioid pain patches market, by patch type, 2018 - 2030 (USD Million)
  • Table 36 Asia Pacific non-opioid pain patches market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 37 Japan non-opioid pain patches market, by patch type, 2018 - 2030 (USD Million)
  • Table 38 Japan non-opioid pain patches market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 39 China non-opioid pain patches market, by patch type, 2018 - 2030 (USD Million)
  • Table 40 China non-opioid pain patches market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 41 India non-opioid pain patches market, by patch type, 2018 - 2030 (USD Million)
  • Table 42 India non-opioid pain patches market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 43 Australia non-opioid pain patches market, by patch type, 2018 - 2030 (USD Million)
  • Table 44 Australia non-opioid pain patches market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 45 South Korea non-opioid pain patches market, by patch type, 2018 - 2030 (USD Million)
  • Table 46 South Korea non-opioid pain patches market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 47 Thailand non-opioid pain patches market, by patch type, 2018 - 2030 (USD Million)
  • Table 48 Thailand non-opioid pain patches market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 49 Latin America non-opioid pain patches market, by country, 2018 - 2030 (USD Million)
  • Table 50 Latin America non-opioid pain patches market, by patch type, 2018 - 2030 (USD Million)
  • Table 51 Latin America non-opioid pain patches market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 52 Brazil non-opioid pain patches market, by patch type, 2018 - 2030 (USD Million)
  • Table 53 Brazil non-opioid pain patches market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 54 Argentina non-opioid pain patches market, by patch type, 2018 - 2030 (USD Million)
  • Table 55 Argentina non-opioid pain patches market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 56 Middle East & Africa Non-opioid pain patches market, by country, 2018 - 2030 (USD Million)
  • Table 57 Middle East & Africa non-opioid pain patches market, by patch type, 2018 - 2030 (USD Million)
  • Table 58 Middle East & Africa non-opioid pain patches market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 59 South Africa non-opioid pain patches market, by patch type, 2018 - 2030 (USD Million)
  • Table 60 South Africa non-opioid pain patches market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 61 Saudi Arabia non-opioid pain patches market, by patch type, 2018 - 2030 (USD Million)
  • Table 62 Saudi Arabia non-opioid pain patches market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 63 UAE non-opioid pain patches market, by patch type, 2018 - 2030 (USD Million)
  • Table 64 UAE non-opioid pain patches market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 65 Kuwait non-opioid pain patches market, by patch type, 2018 - 2030 (USD Million)
  • Table 66 Kuwait non-opioid pain patches market, by distribution channel, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Non-opioid pain patches market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Patch type and distribution channel outlook (USD Million)
  • Fig. 10 Competitive landscape
  • Fig. 11 Non-opioid pain patches market dynamics
  • Fig. 12 Non-opioid pain patches market: Porter's five forces analysis
  • Fig. 13 Non-opioid pain patches market: PESTLE analysis
  • Fig. 14 Non-opioid pain patches market: Patch type segment dashboard
  • Fig. 15 Non-opioid pain patches market: Patch type market share analysis, 2024 & 2030
  • Fig. 16 Lidocaine patches market, 2018 - 2030 (USD Million)
  • Fig. 17 Diclofenac patches market, 2018 - 2030 (USD Million)
  • Fig. 18 Methyl salicylate patches market, 2018 - 2030 (USD Million)
  • Fig. 19 Capsaicin patches market, 2018 - 2030 (USD Million)
  • Fig. 20 Ketoprofen patches market, 2018 - 2030 (USD Million)
  • Fig. 21 Others (herbal, menthol, etc.) market, 2018 - 2030 (USD Million)
  • Fig. 22 Non-opioid pain patches market: Distribution channel segment dashboard
  • Fig. 23 Non-opioid pain patches market: Distribution channel market share analysis, 2024 & 2030
  • Fig. 24 Retail pharmacies market, 2018 - 2030 (USD Million)
  • Fig. 25 Hospital pharmacies market, 2018 - 2030 (USD Million)
  • Fig. 26 Online pharmacies market, 2018 - 2030 (USD Million)
  • Fig. 27 Others (supermarkets/hypermarkets, DTC) market, 2018 - 2030 (USD Million)
  • Fig. 28 Non-opioid pain patches market revenue, by region
  • Fig. 29 Regional marketplace: Key takeaways
  • Fig. 30 Regional marketplace: Key takeaways
  • Fig. 31 North America non-opioid pain patches market, 2018 - 2030 (USD Million)
  • Fig. 32 U.S. country dynamics
  • Fig. 33 U.S. non-opioid pain patches market, 2018 - 2030 (USD Million)
  • Fig. 34 Canada country dynamics
  • Fig. 35 Canada non-opioid pain patches market, 2018 - 2030 (USD Million)
  • Fig. 36 Mexico country dynamics
  • Fig. 37 Mexico non-opioid pain patches market, 2018 - 2030 (USD Million)
  • Fig. 38 Europe non-opioid pain patches market, 2018 - 2030 (USD Million)
  • Fig. 39 UK country dynamics
  • Fig. 40 UK non-opioid pain patches market, 2018 - 2030 (USD Million)
  • Fig. 41 Germany country dynamics
  • Fig. 42 Germany non-opioid pain patches market, 2018 - 2030 (USD Million)
  • Fig. 43 France country dynamics
  • Fig. 44 France non-opioid pain patches market, 2018 - 2030 (USD Million)
  • Fig. 45 Italy country dynamics
  • Fig. 46 Italy non-opioid pain patches market, 2018 - 2030 (USD Million)
  • Fig. 47 Spain country dynamics
  • Fig. 48 Spain non-opioid pain patches market, 2018 - 2030 (USD Million)
  • Fig. 49 Norway country dynamics
  • Fig. 50 Norway non-opioid pain patches market, 2018 - 2030 (USD Million)
  • Fig. 51 Sweden country dynamics
  • Fig. 52 Sweden non-opioid pain patches market, 2018 - 2030 (USD Million)
  • Fig. 53 Denmark country dynamics
  • Fig. 54 Denmark non-opioid pain patches market, 2018 - 2030 (USD Million)
  • Fig. 55 Asia Pacific non-opioid pain patches market, 2018 - 2030 (USD Million)
  • Fig. 56 Japan country dynamics
  • Fig. 57 Japan non-opioid pain patches market, 2018 - 2030 (USD Million)
  • Fig. 58 China country dynamics
  • Fig. 59 China non-opioid pain patches market, 2018 - 2030 (USD Million)
  • Fig. 60 India country dynamics
  • Fig. 61 India non-opioid pain patches market, 2018 - 2030 (USD Million)
  • Fig. 62 Australia country dynamics
  • Fig. 63 Australia non-opioid pain patches market, 2018 - 2030 (USD Million)
  • Fig. 64 South Korea country dynamics
  • Fig. 65 South Korea non-opioid pain patches market, 2018 - 2030 (USD Million)
  • Fig. 66 Thailand country dynamics
  • Fig. 67 Thailand non-opioid pain patches market, 2018 - 2030 (USD Million)
  • Fig. 68 Latin America non-opioid pain patches market, 2018 - 2030 (USD Million)
  • Fig. 69 Brazil country dynamics
  • Fig. 70 Brazil non-opioid pain patches market, 2018 - 2030 (USD Million)
  • Fig. 71 Argentina country dynamics
  • Fig. 72 Argentina non-opioid pain patches market, 2018 - 2030 (USD Million)
  • Fig. 73 MEA non-opioid pain patches market, 2018 - 2030 (USD Million)
  • Fig. 74 South Africa country dynamics
  • Fig. 75 South Africa non-opioid pain patches market, 2018 - 2030 (USD Million)
  • Fig. 76 Saudi Arabia country dynamics
  • Fig. 77 Saudi Arabia non-opioid pain patches market, 2018 - 2030 (USD Million)
  • Fig. 78 UAE country dynamics
  • Fig. 79 UAE non-opioid pain patches market, 2018 - 2030 (USD Million)
  • Fig. 80 Kuwait country dynamics
  • Fig. 81 Kuwait non-opioid pain patches market, 2018 - 2030 (USD Million)
  • Fig. 82 Company categorization
  • Fig. 83 Company market position analysis
  • Fig. 84 Strategic framework
目次
Product Code: GVR-4-68038-003-3

Non-opioid Pain Patches Market Growth & Trends:

The global non-opioid pain patches market size is expected to reach USD 1.4 billion by 2030, expanding at a CAGR of 6.2% during the forecast period, according to a new report by Grand View Research, Inc. Some of the key factors driving the market are rising incidence of pain related disorders and the various benefits offered by these patches over other forms of medication used to alleviate acute and chronic pain.

According to the AAPM, chronic pain affects more individuals than cancer, diabetes, and coronary heart disease combined in the U.S. Estimates from the American Chiropractic Association indicate that American citizens spend at least USD 50 billion every year on back-related ailments. These facts are indicative of the growing need for therapies to alleviate pain globally.

Opioid medications are usually sought for the treatment of pain and related disorders despite resulting in dependence and abuse in majority of patients. The rising addiction to opioid drugs has encouraged many countries to develop alternate therapies to alleviate discomfort. In November 2017, opioid epidemic in the U.S. was declared as a national emergency. Thus, demand for safe and effective therapies that ease the underlying discomfort with reduced adverse effects are sought by governments, thus accelerating the market growth.

According to a new study published by Substance Abuse and Mental Health Services Administration report in 2015, 1 in 3 adults in America were prescribed painkillers by medical providers. Statistics from the same source also indicate that these medications were used more than cigarettes, cigars, and smokeless tobacco combined. Most of these oral medicines fall under the opiate category are usually more prone to be addictive and used in combination with other consumables such as alcohol and other drugs. Growing awareness about the adverse effects associated with these drugs has led to the development of alternatives such as non-opioid pain patches to deliver the same therapeutic effect and aid in pain management.

Non-opioid Pain Patches Market Report Highlights:

  • Licodaine patches held the largest market share of 35.0% in 2024, owing to their established efficacy in alleviating various pain types, including neuropathic and musculoskeletal pain.
  • Retail pharmacies dominated the market with a revenue share of 44.6% in 2024. A variety of non-opioid pain patches are available over-the-counter, enabling customers to purchase them without prescriptions.
  • North America held the largest revenue share due to local presence of major non-opioid pain patch market players and increasing R&D in the field of pain management to cater to a rising number of patients
  • The Asia Pacific region is expected to account for the highest CAGR during the forecast period owing to rise in investments by dominant players in the region and developments in the pharmaceutical industry in emerging countries such as India and China

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Patch Type
    • 1.2.2. Distribution Channel
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Non-opioid Pain Patches Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis

Chapter 4. Non-opioid Pain Patches Market: Patch Type Business Analysis

  • 4.1. Patch Type Market Share, 2024 & 2030
  • 4.2. Patch Type Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Patch Type, 2018 to 2030 (USD Million)
  • 4.4. Lidocaine Patches
    • 4.4.1. Lidocaine Patches Market, 2018 - 2030 (USD Million)
  • 4.5. Diclofenac Patches
    • 4.5.1. Diclofenac Patches Market, 2018 - 2030 (USD Million)
  • 4.6. Methyl Salicylate Patches
    • 4.6.1. Methyl Salicylate Patches Market, 2018 - 2030 (USD Million)
  • 4.7. Capsaicin Patches
    • 4.7.1. Capsaicin Patches Market, 2018 - 2030 (USD Million)
  • 4.8. Ketoprofen Patches
    • 4.8.1. Ketoprofen Patches Market, 2018 - 2030 (USD Million)
  • 4.9. Others (Herbal, Menthol, etc.)
    • 4.9.1. Others (Herbal, Menthol, etc.) Market, 2018 - 2030 (USD Million)

Chapter 5. Non-opioid Pain Patches Market: Distribution Channel Business Analysis

  • 5.1. Distribution Channel Market Share, 2024 & 2030
  • 5.2. Distribution Channel Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Distribution Channel, 2018 to 2030 (USD Million)
  • 5.4. Retail Pharmacies
    • 5.4.1. Retail Pharmacies Market, 2018 - 2030 (USD Million)
  • 5.5. Hospital Pharmacies
    • 5.5.1. Hospital Pharmacies Market, 2018 - 2030 (USD Million)
  • 5.6. Online Pharmacies
    • 5.6.1. Online Pharmacies Market, 2018 - 2030 (USD Million)
  • 5.7. Others (Supermarkets/Hypermarkets, DTC)
    • 5.7.1. Others (Supermarkets/Hypermarkets, DTC) Market, 2018 - 2030 (USD Million)

Chapter 6. Non-opioid Pain Patches Market: Regional Estimates & Trend Analysis by Patch Type and Distribution Channel

  • 6.1. Regional Market Share Analysis, 2024 & 2030
  • 6.2. Regional Market Dashboard
  • 6.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 6.4. North America
    • 6.4.1. North America Non-opioid Pain Patches Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 6.4.2. U.S.
      • 6.4.2.1. Key Country Dynamics
      • 6.4.2.2. Regulatory Framework
      • 6.4.2.3. Competitive Insights
      • 6.4.2.4. U.S. Non-opioid Pain Patches Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.4.3. Canada
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. Regulatory Framework
      • 6.4.3.3. Competitive Insights
      • 6.4.3.4. Canada Non-opioid Pain Patches Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.4.4. Mexico
      • 6.4.4.1. Key Country Dynamics
      • 6.4.4.2. Regulatory Framework
      • 6.4.4.3. Competitive Insights
      • 6.4.4.4. Mexico Non-opioid Pain Patches Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Europe
    • 6.5.1. Europe Non-opioid Pain Patches Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 6.5.2. UK
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Regulatory Framework
      • 6.5.2.3. Competitive Insights
      • 6.5.2.4. UK Non-opioid Pain Patches Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.3. Germany
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Regulatory Framework
      • 6.5.3.3. Competitive Insights
      • 6.5.3.4. Germany Non-opioid Pain Patches Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.4. France
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Regulatory Framework
      • 6.5.4.3. Competitive Insights
      • 6.5.4.4. France Non-opioid Pain Patches Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.5. Italy
      • 6.5.5.1. Key Country Dynamics
      • 6.5.5.2. Regulatory Framework
      • 6.5.5.3. Competitive Insights
      • 6.5.5.4. Italy Non-opioid Pain Patches Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.6. Spain
      • 6.5.6.1. Key Country Dynamics
      • 6.5.6.2. Regulatory Framework
      • 6.5.6.3. Competitive Insights
      • 6.5.6.4. Spain Non-opioid Pain Patches Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.7. Norway
      • 6.5.7.1. Key Country Dynamics
      • 6.5.7.2. Regulatory Framework
      • 6.5.7.3. Competitive Insights
      • 6.5.7.4. Norway Non-opioid Pain Patches Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.8. Denmark
      • 6.5.8.1. Key Country Dynamics
      • 6.5.8.2. Regulatory Framework
      • 6.5.8.3. Competitive Insights
      • 6.5.8.4. Denmark Non-opioid Pain Patches Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.9. Sweden
      • 6.5.9.1. Key Country Dynamics
      • 6.5.9.2. Regulatory Framework
      • 6.5.9.3. Competitive Insights
      • 6.5.9.4. Sweden Non-opioid Pain Patches Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Asia Pacific
    • 6.6.1. Asia Pacific Non-opioid Pain Patches Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 6.6.2. Japan
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Regulatory Framework
      • 6.6.2.3. Competitive Insights
      • 6.6.2.4. Japan Non-opioid Pain Patches Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.6.3. China
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Regulatory Framework
      • 6.6.3.3. Competitive Insights
      • 6.6.3.4. China Non-opioid Pain Patches Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.6.4. India
      • 6.6.4.1. Key Country Dynamics
      • 6.6.4.2. Regulatory Framework
      • 6.6.4.3. Competitive Insights
      • 6.6.4.4. India Non-opioid Pain Patches Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.6.5. South Korea
      • 6.6.5.1. Key Country Dynamics
      • 6.6.5.2. Regulatory Framework
      • 6.6.5.3. Competitive Insights
      • 6.6.5.4. South Korea Non-opioid Pain Patches Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.6.6. Australia
      • 6.6.6.1. Key Country Dynamics
      • 6.6.6.2. Regulatory Framework
      • 6.6.6.3. Competitive Insights
      • 6.6.6.4. Australia Non-opioid Pain Patches Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.6.7. Thailand
      • 6.6.7.1. Key Country Dynamics
      • 6.6.7.2. Regulatory Framework
      • 6.6.7.3. Competitive Insights
      • 6.6.7.4. Thailand Non-opioid Pain Patches Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.7. Latin America
    • 6.7.1. Latin America Non-opioid Pain Patches Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 6.7.2. Brazil
      • 6.7.2.1. Key Country Dynamics
      • 6.7.2.2. Regulatory Framework
      • 6.7.2.3. Competitive Insights
      • 6.7.2.4. Brazil Non-opioid Pain Patches Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.7.3. Argentina
      • 6.7.3.1. Key Country Dynamics
      • 6.7.3.2. Regulatory Framework
      • 6.7.3.3. Competitive Insights
      • 6.7.3.4. Argentina Non-opioid Pain Patches Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.8. MEA
    • 6.8.1. MEA Non-opioid Pain Patches Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 6.8.2. South Africa
      • 6.8.2.1. Key Country Dynamics
      • 6.8.2.2. Regulatory Framework
      • 6.8.2.3. Competitive Insights
      • 6.8.2.4. South Africa Non-opioid Pain Patches Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.8.3. Saudi Arabia
      • 6.8.3.1. Key Country Dynamics
      • 6.8.3.2. Regulatory Framework
      • 6.8.3.3. Competitive Insights
      • 6.8.3.4. Saudi Arabia Non-opioid Pain Patches Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.8.4. UAE
      • 6.8.4.1. Key Country Dynamics
      • 6.8.4.2. Regulatory Framework
      • 6.8.4.3. Competitive Insights
      • 6.8.4.4. UAE Non-opioid Pain Patches Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.8.5. Kuwait
      • 6.8.5.1. Key Country Dynamics
      • 6.8.5.2. Regulatory Framework
      • 6.8.5.3. Competitive Insights
      • 6.8.5.4. Kuwait Non-opioid Pain Patches Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Participant Overview
  • 7.2. Company Market Position Analysis
  • 7.3. Company Categorization
  • 7.4. Strategy Mapping
  • 7.5. Company Profiles/Listing
    • 7.5.1. Acorda Therapeutics, Inc.
      • 7.5.1.1. Overview
      • 7.5.1.2. Financial Performance
      • 7.5.1.3. Product Benchmarking
      • 7.5.1.4. Strategic Initiatives
    • 7.5.2. Teva Pharmaceutical Industries Ltd.
      • 7.5.2.1. Overview
      • 7.5.2.2. Financial Performance
      • 7.5.2.3. Product Benchmarking
      • 7.5.2.4. Strategic Initiatives
    • 7.5.3. GSK plc
      • 7.5.3.1. Overview
      • 7.5.3.2. Financial Performance
      • 7.5.3.3. Product Benchmarking
      • 7.5.3.4. Strategic Initiatives
    • 7.5.4. Endo, Inc.
      • 7.5.4.1. Overview
      • 7.5.4.2. Financial Performance
      • 7.5.4.3. Product Benchmarking
      • 7.5.4.4. Strategic Initiatives
    • 7.5.5. Hisamitsu Pharmaceutical Co.,Inc.
      • 7.5.5.1. Overview
      • 7.5.5.2. Financial Performance
      • 7.5.5.3. Product Benchmarking
      • 7.5.5.4. Strategic Initiatives
    • 7.5.6. IBSA Institut Biochimique SA
      • 7.5.6.1. Overview
      • 7.5.6.2. Financial Performance
      • 7.5.6.3. Product Benchmarking
      • 7.5.6.4. Strategic Initiatives
    • 7.5.7. Alkermes
      • 7.5.7.1. Overview
      • 7.5.7.2. Financial Performance
      • 7.5.7.3. Product Benchmarking
      • 7.5.7.4. Strategic Initiatives
    • 7.5.8. Teikoku Pharma
      • 7.5.8.1. Overview
      • 7.5.8.2. Financial Performance
      • 7.5.8.3. Product Benchmarking
      • 7.5.8.4. Strategic Initiatives
    • 7.5.9. Mylan N.V.
      • 7.5.9.1. Overview
      • 7.5.9.2. Financial Performance
      • 7.5.9.3. Product Benchmarking
      • 7.5.9.4. Strategic Initiatives